New England Capital Financial Advisors LLC

Position in PFE — Pfizer Inc

CIK 1964652 MERIDEN, CT

Position in PFE

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$137,569

-$23,217 QoQ

Shares Held

5,713

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#1,035

of 1,181 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New England Capital Financial Advisors LLC holds $1,698,786 across 11 Drug Manufacturers - General names. PFE ranks #4 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,860	$726,354
2	MRK	Merck & Co., Inc.	2,193	$281,800
3	BMY	Bristol Myers Squibb Co	4,319	$248,860
4	PFE	Pfizer Inc This page	5,713	$137,569
5	AZN	Astrazeneca PLC	560	$106,187
6	ABBV	AbbVie Inc.	363	$91,345
7	GILD	Gilead Sciences, Inc.	390	$49,272
8	LLY	ELI LILLY & Co	34	$40,780

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$137,569	5,713	-0.2%	Shares	Sole	2026-07-27
2026-03-31	$160,786	5,726	+0.1%	Shares	Sole	2026-04-27
2025-12-31	$142,428	5,720	+0.1%	Shares	Sole	2026-02-02
2025-09-30	$145,567	5,713	-12.5%	Shares	Sole	2025-10-22
2025-06-30	$158,214	6,527	+3.2%	Shares	Sole	2025-08-08
2025-03-31	$160,275	6,325	+0.1%	Shares	Sole	2025-05-05
2024-12-31	$167,563	6,316	+0.1%	Shares	Sole	2025-02-04
2024-09-30	$182,524	6,307	-4.5%	Shares	Sole	2024-10-30
2024-06-30	$184,695	6,601	+0.1%	Shares	Sole	2024-07-29
2024-03-31	$182,955	6,593	+0.1%	Shares	Sole	2024-05-02
2023-12-31	$189,553	6,584	+0.3%	Shares	Sole	2024-02-01
2023-09-30	$217,761	6,565	+0.3%	Shares	Sole	2023-11-06
2023-06-30	$240,070	6,545	-1.0%	Shares	Sole	2023-08-02
2023-03-31	$269,851	6,614	+0.1%	Shares	Sole	2023-05-04
2022-12-31	$338,440	6,605	—	Shares	Sole	2023-02-06
No filing history on record for this holder in this stock.